The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

DuPont Reports 4Q and Full-Year 2012 EPS of $.11 and $3.33 Ex-items

Tuesday, January 22, 2013

DuPont Reports 4Q and Full-Year 2012 EPS of $.11 and $3.33 Ex-items06:00 EST Tuesday, January 22, 2013Expects Modest Growth in 2013 Operating EarningsWILMINGTON, Del., Jan. 22, 2013 /PRNewswire/ --Fourth Quarter:Fourth quarter 2012 earnings per share (EPS) from continuing operations, excluding significant items, was $.11 versus prior year earnings of $.26.  Reported fourth quarter 2012 EPS from continuing operations was $.02 versus $.31 in the prior year.Sales of $7.3 billion equaled the prior year.  Three percent higher volume was offset by 2 percent negative currency impact and a 1 percent reduction from portfolio changes.  Segment pre-tax operating income (PTOI) was down, primarily reflecting lower price and volume in Performance Chemicals.  Titanium dioxide pricing led the decline.  Full Year:2012 EPS from continuing operations, excluding significant items, was $3.33 versus $3.55 in 2011.  Currency was a $.27 per share headwind for the year.  Reported EPS from continuing operations was $2.61 versus $3.30 in 2011 (see Schedule B.) Sales were $34.8 billion, up 3 percent with a 6 percent increase in developing markets. Segment PTOI increased 3 percent to $5.7 billion, excluding Pharmaceuticals and significant items.  Agriculture PTOI increased 18 percent driven by volume and pricing growth for seed and crop protection businesses in North America and Latin America.  Performance Chemicals PTOI decreased 16 percent from lower sales across the segment.Free cash flow was $3.1 billion versus $3.3 billion in the prior year.  2012 includes a $0.5 billion contribution to the principal U.S. pension plan and lower net income, partly offset by improved working capital productivity. Fixed cost and working capital productivity benefits were each about $400 million, surpassing their $300 million targets.Reflecting the change in reporting for the cost of non-operating pension and other post-employment benefits and excluding significant items, 2012 operating earnings were $3.77 per share.  On the same basis, the 2013 outlook for operating earnings is $3.85 to $4.05 per share, an increase of 2 to 7 percent over the prior year."DuPont stands stronger today than it did a year ago.  Our segments delivered innovation, productivity and integration cost synergies.  This, coupled with a record year in new product introductions, has strengthened our market position," said DuPont Chair and CEO Ellen Kullman.  "However, weakness in markets served by Performance Chemicals and Electronics & Communications provided significant challenges in 2012.  We've adjusted our plans to meet the changing market environment and grow our businesses in a slow-growth world economy."Global Consolidated Sales  - 4th QuarterFourth quarter 2012 sales were $7.3 billion, flat versus the prior year.  Currency impact and portfolio changes offset 3 percent volume growth.  Volume was driven by Agriculture, with robust sales in Latin America and a strong start to the North American selling season, and increases in Asia Pacific for Performance Materials, Electronics & Communications and Performance Chemicals.  The table below shows fourth quarter regional sales and variances versus fourth quarter 2011.Three Months Ended December 31, 2012Percentage Change Due to:(Dollars in billions)$% ChangeLocalPriceCurrency EffectVolumePortfolio/OtherU.S. & Canada$     2.5-2--(2)EMEA*1.6(8)(1)(4)(2)(1)Asia Pacific1.9-(5)(1)6-Latin America1.3107(4)8(1)Total Consolidated Sales$     7.3--(2)3(1)Global Consolidated Sales - Full-YearFull-year 2012 sales were $34.8 billion, up 3 percent versus 2011, reflecting 4 percent higher local prices, 2 percent adverse currency impact, 2 percent lower volume, and a 3 percent net increase from portfolio changes.  Local prices increased for all segments except Electronics & Communications which had lower pass-through of metals prices.  Lower global volume principally reflects decreases for Performance Chemicals and Electronics & Communications, partly offset by higher Agriculture volumes.  The table below shows regional sales and variances versus 2011.Year Ended December 31, 2012Percentage Change Due to:(Dollars in billions)$% ChangeLocalPriceCurrency EffectVolumePortfolio/OtherU.S. & Canada$   14.286--2EMEA*8.1(1)3(6)(4)6Asia Pacific8.0(4)(1)(1)(5)3Latin America4.5119(5)52Total Consolidated Sales$   34.834(2)(2)3* Europe, Middle East & AfricaIncome from Continuing Operations - 4th QuarterExcluding significant items, fourth quarter 2012 income from continuing operations was $110 million versus $246 million in the prior year.  The decrease principally reflects lower income from Performance Chemicals and Pharmaceuticals, increased spending for growth initiatives and adverse currency impact.  Reported fourth quarter 2012 income from continuing operations was $19 million versus $293 million in the fourth quarter 2011. Earnings Per Share - 4th QuarterThe table below shows year-over-year earnings per share (EPS) variances for the fourth quarter.EPS  ANALYSIS4QEPS 2011$.31   Less: Significant items - (schedule B).05EPS 2011 ?Excluding significant items.26   Local prices(.01)   Variable cost*.12   Volume(.03)   Fixed cost*(.12)   Currency(.04)   Income tax.04   Pharmaceuticals income(.06)   Other**(.05)EPS 2012 ? Excluding significant items   $.11   Add: Significant items - (schedule B)(.09)EPS 2012$.02*  Excludes volume and currency impacts** Includes interest expense, net exchange gains/losses, and other income Business Segment Performance - 4th QuarterThe tables below show fourth quarter 2012 segment sales with  related variances versus the prior year and fourth quarter PTOI excluding significant items.SEGMENT SALES*Three Months EndedPercentage Change (Dollars in billions)December 31, 2012Due to:$% ChangeUSDPriceVolumePortfolioand OtherAgriculture$      1.518711-Electronics & Communications 0.6(1)(3)2-Industrial Biosciences0.3413-Nutrition & Health0.9633-Performance Chemicals1.6(15)(7)(8)-Performance Materials1.5(5)(5)3(3)Safety & Protection1.02(1)3-*    Segment sales include transfers SEGMENT PTOI excluding Significant Items*Change versus 2011(Dollars in millions)4Q 20124Q 2011$%Agriculture$     (92)$   (116)$      2421%Electronics & Communications2442(18)-43%Industrial Biosciences44341029%Nutrition & Health66521427%Performance Chemicals200433(233)-54%Performance Materials25415110368%Safety & Protection8894(6)-6%Other(71)(74)3nm$     513$     616$   (103)-17%Pharmaceuticals989(80)-90%Total Segment PTOI$     522$     705$   (183)-26%* See Schedules B and C for listing of significant items and their impact by segment. Business Segment Performance - Full YearThe tables below show full-year 2012 segment sales with related variances versus the prior year, and full-year PTOI excluding significant items.12 Months EndedPercentage Change SEGMENT SALES*December 31, 2012Due to:(Dollars in billions)$% ChangeUSDPriceVolumePortfolioand OtherAgriculture$    10.41468-Electronics & Communications 2.7(15)(4)(11)-Industrial Biosciences1.267(4)863Nutrition & Health3.4391335Performance Chemicals7.2(8)4(12)-Performance Materials6.4(5)(2)-(3)Safety & Protection3.8(3)-(3)-*    Segment sales include transfers SEGMENT PTOI excluding Significant Items*(Dollars in millions)Change versus 2011FY 2012FY 2011$%Agriculture$  2,063$   1,752$      31118%Electronics & Communications172355(183)-52%Industrial Biosciences1717893119%Nutrition & Health348170178105%Performance Chemicals1,6221,923(301)-16%Performance Materials1,11792419321%Safety & Protection418500(82)-16%Other(259)(235)(24)nm$  5,652$   5,467$      1853%Pharmaceuticals62289(227)-79%Total Segment PTOI$  5,714$   5,756$       (42)-1%* See Schedules B and C for listing of significant items and their impact by segment.The following is a summary of business results for each of the company's reportable segments in the fourth quarter (unless otherwise noted), comparing current period with the prior year, for sales and PTOI (loss) excluding significant items.  References to selling price are on a U.S. dollar basis, including the impact of currency.Agriculture ? Sales of $1.5 billion were up 18 percent on 11 percent higher volume and 7 percent higher prices despite the negative impact of currency.  PTOI seasonal loss of ($92) million improved $24 million on higher volume in Latin America and stronger than expected pricing gains, partially offset by continued investment in commercial and R&D activities.  Full-year sales of $10.4 billion grew 14 percent on 8 percent higher volume and 6 percent higher prices.  Pioneer seed sales increased from higher global volume and pricing gains in corn and soybeans.  Crop Protection sales grew on strong demand for insecticides and herbicides in all regions.  Full-year PTOI increased 18 percent as strong sales more than offset unfavorable currency and higher investments in commercial and R&D activities to support growth.   Electronics & Communications ? Sales of $622 million were down 1 percent, with 2 percent higher volume offset by3 percent lower prices, primarily pass-through of lower metals prices.  Volume growth from increased demand for materials in smart phones and tablets was partly offset by continued softness in photovoltaic materials.  PTOI declined $18 million as the prior year included OLED technology licensing income of $20 million.Industrial Biosciences ? Sales of $300 million were up 4 percent on 3 percent higher volume and 1 percent higher prices.  Volume growth reflects strong sales of Sorona® polymer for carpeting, and continued growth in food enzymes in Europe.  PTOI of $44 million was up $10 million on higher volume and the benefit of synergies realized from the integration of the Danisco enzyme business.Nutrition & Health ? Sales of $853 million were up 6 percent on 3 percent higher volume and 3 percent higher prices.  Volume growth reflects strong demand for probiotics, cultures and enablers.  Higher local prices in all regions were partly offset by unfavorable currency.  PTOI of $66 million was up $14 million on higher sales and the benefit of synergies realized from the integration of the Danisco specialty food ingredients business, partly offset by higher raw material costs.Performance Chemicals ? Sales of $1.6 billion were down 15 percent, with 8 percent lower volume and 7 percent lower prices.  Lower volume resulted primarily from weak demand for fluoropolymers in U.S. and Europe.  Lower prices reflect cyclical pressure in the titanium dioxide market.  PTOI of $200 million decreased $233 million on lower sales and plant utilization in both businesses. Performance Materials ? Sales of $1.5 billion were down 5 percent, with 5 percent lower prices and a 3 percent reduction from a portfolio change, partly offset by 3 percent higher volume.  Stable packaging markets and strong demand in the North American automotive market were partially offset by softness in the industrial and electronics markets and a weak Europe.  PTOI of $254 million increased $103 million due to lower feedstock costs, higher volume and mix enrichment, partly offset by unfavorable currency.  Safety & Protection ? Sales of $964 million were up 2 percent on 3 percent higher volume, partly offset by 1 percent lower prices due to unfavorable currency.  Volume increased on higher demand for Sustainable Solutions offerings and U.S. residential and commercial construction products.  PTOI of $88 million decreased $6 million primarily due to lower plant utilization related to softness in certain industrial markets and U.S. public sector markets.  Additional information is available on the DuPont Investor Center website at http://www.investors.dupont.com.Outlook Reflecting the change in reporting for the cost of non-operating pension and other post-employment benefits and excluding significant items, 2012 operating earnings were $3.77 per share.  On the same basis, the 2013 outlook for operating earnings is $3.85 to $4.05 per share, an increase of 2 to 7 percent over the prior year. First half 2013 operating earnings are expected to decline modestly on a year-over-year basis.  Additionally, full-year 2013 sales are expected to be about $36 billion.Use of Non-GAAP Measures Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company.  Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance.  Reconciliations of non-GAAP measures to GAAP are provided in schedules C and D.DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.Forward-Looking Statements:  This news release contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates" or other words of similar meaning.  All statements that address expectations or projections about the future, including statements about the company's growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements.  Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized.  Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control.  Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; inability to protect and enforce the company's intellectual property rights; and integration of acquired businesses and completion of divestitures of underperforming or non-strategic assets or businesses.  The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.  E. I. du Pont de Nemours and CompanyConsolidated Income Statements(Dollars in millions, except per share amounts)SCHEDULE AThree Months EndedDecember 31,Year EndedDecember 31,2012201120122011Net sales$          7,325$          7,343$        34,812$        33,681Other income, net(a)247338498742Total7,5727,68135,31034,423Cost of goods sold and other operating charges (a)5,9835,92725,60424,874Selling, general and administrative expenses8427913,5673,358Research and development expense (a)5475272,0671,910Interest expense 117116464447Employee separation / asset related charges, net (a)991749353Total7,5887,37832,19530,642(Loss) income from continuing operations before income taxes(16)3033,1153,781(Benefit from) provision for income taxes on continuing operations (35)10622626Income from continuing operations after income taxes192932,4933,155Net income from discontinued operations after taxes9384320355Net income 1123772,8133,510Less:  Net income attributable to noncontrolling interests142536Net income attributable to DuPont   $             111$             373$          2,788$          3,474Basic earnings per share of common stock (b):Basic earnings per share of common stock from continuing operations$            0.02$            0.31$            2.63$            3.35Basic earnings per share of common stock from discontinued operations0.100.090.340.38Basic earnings per share of common stock$            0.12$            0.40$            2.98$            3.73Diluted earnings per share of common stock (b):Diluted earnings per share of common stock from continuing operations$            0.02$            0.31$            2.61$            3.30Diluted earnings per share of common stock from discontinued operations0.100.090.340.38Diluted earnings per share of common stock$            0.12$            0.40$            2.95$            3.68Dividends per share of common stock   $            0.43$            0.41$            1.70$            1.64Average number of shares outstanding used in earnings per share (EPS) calculation:  Basic933,420,000925,588,000933,275,000928,417,000  Diluted941,219,000935,709,000942,197,000941,029,000(a) See Schedule B for detail of significant items.(b) The sum of the individual earnings per share amounts may not equal the total due to rounding.   E. I. du Pont de Nemours and CompanyCondensed Consolidated Balance Sheets(Dollars in millions, except per share amounts)SCHEDULE A (continued)December 31, 2012December 31, 2011AssetsCurrent assetsCash and cash equivalents$           4,284$           3,586Marketable securities123433Accounts and notes receivable, net 5,4526,022Inventories 7,4227,195Prepaid expenses204151Deferred income taxes 650671Assets held for sale3,056-Total current assets21,19118,058Property, plant and equipment, net of accumulated depreciation    (December 31, 2012 - $19,085; December 31, 2011 - $19,349)12,74113,412Goodwill4,6165,413Other intangible assets 5,1265,413Investment in affiliates1,1631,117Deferred income taxes 3,9394,067Other assets9601,012Total$         49,736$         48,492Liabilities and EquityCurrent liabilitiesAccounts payable$           4,853$           4,816Short-term borrowings and capital lease obligations 1,275817Income taxes 340255Other accrued liabilities5,9975,297Liabilities related to assets held for sale1,084-Total current liabilities13,54911,185Long-term borrowings and capital lease obligations 10,46511,736Other liabilities14,68715,508Deferred income taxes8561,001Total liabilities39,55739,430Commitments and contingent liabilities Stockholders' equityPreferred stock237237Common stock, $0.30 par value; 1,800,000,000 shares authorized;    Issued at December 31, 2012 - 1,020,057,000; December 31, 2011 - 1,013,164,000306304Additional paid-in capital10,63210,107Reinvested earnings14,28613,422Accumulated other comprehensive loss (8,646)(8,750)Common stock held in treasury, at cost (87,041,000 shares    at December 31, 2012 and 2011)(6,727)(6,727)Total DuPont stockholders' equity10,0888,593Noncontrolling interests91469Total equity10,1799,062Total$         49,736$         48,492   E. I. du Pont de Nemours and CompanyCondensed Consolidated Statement of Cash Flows(Dollars in millions, except per share amounts)SCHEDULE A (continued)Year EndedDecember 31,Total Company20122011Cash provided by (used for) operating activities$ 4,849$ 5,152Investing activitiesPurchases of property, plant and equipment(1,793)(1,843)Investments in affiliates(97)(67)Payments for businesses (net of cash acquired)(18)(6,459)Net (increase) decrease in short-term financial instruments3152,149Proceeds from sales of assets - net of cash sold302214Other investing activities - net(55)(232)Cash provided by (used for) investing activities(1,346)(6,238)Financing activitiesDividends paid to stockholders(1,594)(1,533)Net increase (decrease) in borrowings(793)1,561Repurchase of common stock(400)(672)Proceeds from exercise of stock options550952Payments for noncontrolling interest(470)-Other financing activities - net1095Cash provided by (used for) financing activities(2,697)403Effect of exchange rate changes on cash(13)6Cash classified as held for sale(95)-Increase (decrease) in cash and cash equivalents698(677)Cash and cash equivalents at beginning of period3,5864,263Cash and cash equivalents at end of period$ 4,284$ 3,586   E. I. du Pont de Nemours and CompanySchedule of Significant Items from Continuing Operations(Dollars in millions, except per share amounts)SCHEDULE BSIGNIFICANT ITEMS FROM CONTINUING OPERATIONSPre-taxAfter-tax($ Per Share)2012201120122011201220111st QuarterCustomer claims charge (a)$   (50)$       -$   (32)$       -$ (0.04)$        -1st Quarter - Total$   (50)$       -$   (32)$       -$ (0.04)$        -2nd QuarterCustomer claims charge (a)$ (265)$     -$ (169)$     -$ (0.18)$      -Litigation settlement (b)(137)-(123)-(0.13)-Gain on the sale of equity method investment (c)122-77-0.08-Transition costs related to theacquisition of Danisco(d)-(103)-(81)-(0.08)2nd Quarter - Total$ (280)$ (103)$ (215)$   (81)$ (0.23)$ (0.08)3rd QuarterCustomer claims charge (a)$ (125)$   (75)$   (80)$   (48)$ (0.09)$ (0.05)Restructuring charge (e)(152)-(105)-(0.11)-Asset impairment charge (f)(242)-(157)-(0.17)-Transition costs and restructuring chargerelated to the acquisition of Danisco (g)-(171)-(122)-(0.13)Charge related to milestone paymentfor licensing agreement (h)-(50)-(33)-(0.03)3rd Quarter - Total$ (519)$ (296)$ (342)$ (203)$ (0.37)$ (0.21)4th QuarterCustomer claims charge (a)$ (135)$ (100)$   (89)$   (64)$ (0.09)$ (0.07)Restructuring charge/adjustments (i)(66)(17)(56)(11)(0.06)(0.01)Asset impairment charge (j)(33)-(21)-(0.02)-Gain on sale of business (k)117-75-0.08-Sale of a business (l)-49-122-0.134th Quarter - Total$ (117)$   (68)$   (91)$    47$ (0.09)$  0.05Full Year - Total (m)$ (966)$ (467)$ (680)$ (237)$ (0.72)$ (0.25)   E. I. du Pont de Nemours and CompanySchedule of Significant Items from Continuing Operations(Dollars in millions, except per share amounts)SCHEDULE B (continued)SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS(a)Fourth quarter 2012, third quarter 2012, second quarter 2012, first quarter 2012, fourth quarter 2011, and third quarter 2011 included charges of $(135), $(125), $(265), $(50), $(100), and $(75), respectively, recorded in Cost of goods sold and other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis® herbicide, bringing the total charges to $(750) at December 31, 2012.  The company will continue to evaluate reported claim damage as additional information becomes available. It is reasonably possible that additional charges could result from this evaluation. While there is a high degree of uncertainty, total charges could range as high as $(900). The company has an applicable insurance program with a deductible equal to the first $100 of costs and expenses. The insurance program limits are $725 for costs and expenses in excess of the $100. The company has submitted, and will continue to submit, requests for payment to its insurance carriers for costs associated with this matter.  This matter relates to the Agriculture segment.(b)Second quarter 2012 included a charge of $(137) recorded in Cost of goods sold and other operating charges primarily related to the company's settlement of litigation with Invista.  This matter is included in Other.  (c)Second quarter 2012 included a pre-tax gain of $122 recorded in Other income, net associated with the sale of an equity method investment in the Electronics & Communications segment.(d)Second quarter 2011 included charges related to the Danisco acquisition of $(103) recorded in Cost of goods sold and other operating charges.  These charges included $(60) of transaction costs and a $(43) charge related to the fair value step-up of inventories that were acquired from Danisco and sold in the second quarter 2011. Pre-tax charges by segment were: Industrial Biosciences - $(17), Nutrition & Health - $(33), and Corporate expenses - $(53).(e)Third quarter 2012 included a $(152) restructuring charge recorded in Employee separation/asset related charges, net consisting of $(133) of severance and related benefit costs and $(19) of asset related charges as a result of the company's plan to eliminate corporate costs previously allocated to Performance Coatings and cost-cutting actions to improve competitiveness.  Pre-tax charges by segment were: Agriculture - $(3), Nutrition & Health - $(13), Electronics & Communications - $(7), Performance Chemicals - $(3), Performance Materials - $(9), Safety & Protection - $(55), Industrial Biosciences - $(3), and Corporate expenses - $(59).(f)Third quarter 2012 included a $(242) impairment charge recorded in Employee separation/asset related charges, net related to asset groupings within the Electronics & Communications and Performance Materials segments. The charge of $(150) within Electronics & Communications was a result of conditions within the thin film photovoltaic market. The charge of $(92) within Performance Materials was the result of deteriorating conditions in an industrial polymer market.(g)Third quarter 2011 included charges related to the Danisco acquisition of $(171).  These charges included $(135) recorded in Cost of goods sold and other operating charges for $(3) of transaction costs and a $(132) charge related to the fair value step-up of inventories that were acquired from Danisco and sold in the third quarter 2011.  These charges also included a $(36) restructuring charge recorded in Employee separation / asset related charges, net related to severance and related benefit costs.  Pre-tax charges by segment were: Industrial Biosciences - $(61), Nutrition & Health - $(89), Other - $(18), and Corporate expenses - $(3).(h)Third quarter 2011 included a ($50) charge recorded in Research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement.(i)Fourth quarter 2012 included a $(66) restructuring charge recorded in Employee separation/asset related charges, net primarily as a result of the company's plans to eliminate corporate costs previously allocated to Performance Coatings and cost-cutting actions to improve competitiveness, partially offset by a reversal of prior year restructuring accruals. Pre-tax charges by segment are: Agriculture - $(8), Electronics & Communications - $(2), Nutrition & Health - $(36), Performance Materials - $(3), Safety & Protection - $(3), Other - $11, and Corporate expenses - $(25). Fourth quarter 2011 included a $(17) restructuring charge recorded in Employee separation/asset related charges, net primarily related to severance and related benefit costs associated with the Danisco acquisition, partially offset by a reversal of prior year restructuring accruals.  Pre-tax charges by segment were: Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), and Other - $(10).(j)Fourth quarter 2012 included a $(33) impairment charge recorded in Employee separation/asset related charges, net related to an asset group within the Performance Chemicals segment.  The charge was a result of strategic decisions related to deteriorating conditions within a specific industrial chemicals market.(k)Fourth quarter 2012 included a pre-tax gain of $117 recorded in Other income, net associated with the sale of a business within the Agriculture segment.(l)Fourth quarter 2011 included a pre-tax gain of $49 recorded in Other income, net associated with the sale of a business in the Performance Materials segment and a related tax benefit of $73.(m)Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.See Schedule C for detail by segment.   E. I. du Pont de Nemours and CompanyConsolidated Segment Information(Dollars in millions)SCHEDULE CThree Months EndedDecember 31,Year EndedDecember 31,SEGMENT SALES (1)2012201120122011Agriculture$ 1,535$ 1,297$ 10,426$   9,166Electronics & Communications6226302,7013,173Industrial Biosciences3002891,180705Nutrition & Health8538063,4222,460Performance Chemicals1,5881,8607,1887,794Performance Materials1,5341,6186,4476,815Safety & Protection9649433,8253,934Other11540Total Segment sales7,3977,44435,19434,087Elimination of transfers(72)(101)(382)(406)Consolidated net sales$ 7,325$ 7,343$ 34,812$ 33,681(1)   Sales for the reporting segments include transfers.   E. I. du Pont de Nemours and CompanyConsolidated Segment Information(Dollars in millions)SCHEDULE C (continued)Three Months EndedDecember 31,Year EndedDecember 31,PRE-TAX OPERATING INCOME/(LOSS) (PTOI) FROM CONTINUING OPERATIONS2012201120122011Agriculture $ (118)$ (216)$ 1,594$ 1,527Electronics & Communications2242135355Industrial Biosciences4433168(1)Nutrition & Health304829944Performance Chemicals1674331,5861,923Performance Materials2511981,013971Safety & Protection8594360500Pharmaceuticals 98962289Other(60)(84)(385)(263)Total Segment PTOI4306374,8325,345Net exchange gains (losses) (1)(54)(14)(215)(146)Corporate expenses & net interest(392)(320)(1,502)(1,418)(Loss) income before income taxes from continuing operations  $   (16)$  303$ 3,115$ 3,781Three Months EndedDecember 31,Year EndedDecember 31,SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2)2012201120122011Agriculture $   (26)$ (100)$  (469)$  (225)Electronics & Communications(2)-(37)-Industrial Biosciences-(1)(3)(79)Nutrition & Health(36)(4)(49)(126)Performance Chemicals(33)-(36)-Performance Materials(3)47(104)47Safety & Protection(3)-(58)-Pharmaceuticals ----Other11(10)(126)(28)Total significant items by segment$   (92)$   (68)$  (882)$  (411)Three Months EndedDecember 31,Year EndedDecember 31,PTOI EXCLUDING SIGNIFICANT ITEMS2012201120122011Agriculture $   (92)$ (116)$ 2,063$ 1,752Electronics & Communications2442172355Industrial Biosciences443417178Nutrition & Health6652348170Performance Chemicals2004331,6221,923Performance Materials2541511,117924Safety & Protection8894418500Pharmaceuticals 98962289Other(71)(74)(259)(235)Total Segment PTOI excluding significant items$  522$  705$ 5,714$ 5,756(1)  See Schedule D for additional information on exchange gains and losses.(2)  See Schedule B for detail of significant items.   E. I. du Pont de Nemours and CompanyReconciliation of Non-GAAP Measures(Dollars in millions, except per share amounts)SCHEDULE DSummary of Earnings ComparisonsThree Months Ended December 31, Year EndedDecember 31, 20122011% Change20122011% ChangeSegment PTOI$              430$             637-32%$          4,832$          5,345-10%Significant items (benefit) charge included in PTOI (per Schedule C)9268882411Segment PTOI excluding significant items$              522$             705-26%$          5,714$          5,756-1%Income from continuing operations after income taxes$                19$             293-94%$          2,493$          3,155-21%Significant items (benefit) charge included in income fromcontinuing operations after income taxes (per Schedule B)91(47)680237Income from continuing operations after income taxes, excluding significant items$              110$             246-55%$          3,173$          3,392-6%EPS from continuing operations$             0.02$            0.31-94%$            2.61$            3.30-21%Significant items (benefit) charge included in EPS (per Schedule B)0.09(0.05)0.720.25EPS from continuing operations, excluding significant items$             0.11$            0.26-58%$            3.33$            3.55-6%Average number of diluted shares outstanding941,219,000935,709,0001%942,197,000941,029,0000%Reconciliation of Operating Earnings Per Share (EPS) OutlookThe reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs, as presented on December 13, 2012.Year Ended December 31,2013 Outlook2012 ActualOperating EPS $3.85 - $4.05 $            3.77Significant items1Q 2013 U.S. tax law items retroactive to 2012 - estimate0.07-Sale of an equity method investment0.08Customer claims charges(0.39)Restructuring charge/adjustments(0.17)Litigation settlement(0.13)Asset impairment charge(0.19)Sale of business0.08Non-operating pension/OPEB costs - estimate(0.42)(0.47)Impact of LIFO accounting change-0.03Reported EPS from continuing operations $3.50 - $3.70 $            2.61   E. I. du Pont de Nemours and CompanyReconciliation of Non-GAAP Measures(Dollars in millions)SCHEDULE DReconciliations of Adjusted EBIT / EBITDA to Consolidated Income StatementsThree Months EndedDecember 31,Year EndedDecember 31,2012201120122011(Loss) income from continuing operations before income taxes$    (16)$    303$   3,115$   3,781Less: Net income attributable to noncontrolling interests142536Add:  Interest expense 117116464447Adjusted EBIT from continuing operations1004153,5544,192Add: Depreciation and amortization 3943931,6311,451Adjusted EBITDA from continuing operations$    494$    808$   5,185$   5,643Calculation of Free Cash Flow - Total CompanyYear EndedDecember 31,20122011Cash provided by (used for) operating activities$ 4,849$ 5,152Less: Purchases of property, plant and equipment1,7931,843Free cash flow$ 3,056$ 3,309   E. I. du Pont de Nemours and CompanyReconciliation of Non-GAAP Measures(Dollars in millions)SCHEDULE D (continued)Exchange Gains/LossesThe company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated Income Statements. Three Months EndedDecember 31,Year Ended December 31,2012201120122011Subsidiary/Affiliate Monetary Position Gain (Loss)Pre-tax exchange gains (losses) (includes equity affiliates)$         (8)$        (83)$       (58)$        (13)Local tax benefits (expenses)941935Net after-tax impact from subsidiary exchange gains (losses)$           1$        (79)$       (39)$          22Hedging Program Gain (Loss)Pre-tax exchange gains (losses)$       (46)$          69$     (157)$      (133)Tax benefits (expenses)16(24)5446Net after-tax impact from hedging program exchange gains (losses)$       (30)$          45$     (103)$        (87)Total Exchange Gain (Loss)Pre-tax exchange gains (losses)$       (54)$        (14)$     (215)$      (146)Tax benefits (expenses)25(20)7381Net after-tax exchange gains (losses) (1)$       (29)$        (34)$     (142)$        (65)As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."  (1)  The above Net after-tax exchange gains (losses) excludes gains (losses) attributable to discontinued operations of $(3) and $(5) for the three months ended December 31, 2012 and 2011, respectively, and $(14) and $(17) for the year ended December 31, 2012 and 2011, respectively.Reconciliation of Base Income Tax Rate to Effective Income Tax RateBase income tax rate is defined as the effective income tax rate less the effect of exchange gains/losses, as defined above, and significant items. Three Months EndedDecember 31,Year Ended December 31,2012201120122011(Loss) income from continuing operations before income taxes $       (16)$        303$    3,115$     3,781Add:  Significant items - (benefit) charge (2)11768966467Less:  Net exchange (losses) gains(54)(14)(215)(146)Income from continuing operations before income taxes, significant items and exchange gains/losses$       155$        385$    4,296$     4,394(Benefit from) provision for income taxes on continuing operations$       (35)$          10$       622$        626Add:  Tax benefit (expenses) on significant items26115286230          Tax benefits (expenses) on exchange gains/losses25(20)7381Provision for income taxes on continuing operations, excluding taxes on significant items       and exchange gains/losses$         16$        105$       981$        937Effective income tax rate218.8%3.3%20.0%16.6%Significant items effect(227.7%)30.4%2.2%3.6%Tax rate, from continuing operations, before significant items(8.9%)33.7%22.2%20.2%Exchange gains (losses) effect19.2%(6.4%)0.6%1.1%Base income tax rate from continuing operations10.3%27.3%22.8%21.3%(2)  See Schedule B for detail of significant items.   E. I. du Pont de Nemours and CompanyConsolidated Segment Information(Dollars in millions)SCHEDULE EBelow represents the company's estimated 4Q and Full Year 2012 segment operating earnings reflecting the change in reporting for the cost of non-operating pension and other post-employment benefits and excluding significant items.Three Months EndedDecember 31,Year EndedDecember 31,SEGMENT OPERATING EARNINGS20122012Agriculture $                             (78)$           2,138Electronics & Communications43259Industrial Biosciences42162Nutrition & Health58326Performance Chemicals2371,814Performance Materials2731,225Safety & Protection133620Pharmaceuticals 962Other(101)(355)Total Segment Operating Earnings6166,251Significant items benefit (charge)(1)(92)(882)Non-operating pension/OPEB costs(144)(615)LIFO/Other reporting changes5078Total Segment PTOI$                             430$           4,832(1)  See Schedule B for detail of significant items.  SOURCE DuPontFor further information: Media Contact: Michael Hanretta, +1-302-774-4005, michael.j.hanretta@usa.dupont.com; Investor Contact: +1-302-774-4994